Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of KRAS-wildtype rectal cancer

Por Nakamura, Sho, Fukui, Tadahisa, Suzuki, Shuhei, Takeda, Hiroyuki, Watanabe, Kaname, Yoshioka, Takashi
Publicado no Onco Targets Ther (2017)

Targeting the K-Ras - JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation

Por Okada, Masashi, Shibuya, Keita, Sato, Atsushi, Seino, Shizuka, Suzuki, Shuhei, Seino, Manabu, Kitanaka, Chifumi
Publicado em 2014

Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells

Por Shibuya, Keita, Okada, Masashi, Suzuki, Shuhei, Seino, Manabu, Seino, Shizuka, Takeda, Hiroyuki, Kitanaka, Chifumi
Publicado no Oncotarget (2014)

JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells

Por Suzuki, Shuhei, Okada, Masashi, Shibuya, Keita, Seino, Manabu, Sato, Atsushi, Takeda, Hiroyuki, Seino, Shizuka, Yoshioka, Takashi, Kitanaka, Chifumi
Publicado no Oncotarget (2014)

The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo

Por Okada, Masashi, Kuramoto, Kenta, Takeda, Hiroyuki, Watarai, Hikaru, Sakaki, Hirotsugu, Seino, Shizuka, Seino, Manabu, Suzuki, Shuhei, Kitanaka, Chifumi
Publicado no Oncotarget (2016)

Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson’s disease, as an anti-cancer stem cell drug

Por Okada, Masashi, Takeda, Hiroyuki, Sakaki, Hirotsugu, Kuramoto, Kenta, Suzuki, Shuhei, Sanomachi, Tomomi, Togashi, Keita, Seino, Shizuka, Kitanaka, Chifumi
Publicado no Oncotarget (2017)

Licochalcone A specifically induces cell death in glioma stem cells via mitochondrial dysfunction

Por Kuramoto, Kenta, Suzuki, Shuhei, Sakaki, Hirotsugu, Takeda, Hiroyuki, Sanomachi, Tomomi, Seino, Shizuka, Narita, Yoshitaka, Kayama, Takamasa, Kitanaka, Chifumi, Okada, Masashi
Publicado no FEBS Open Bio (2017)

The Role of Cancer Boards in the Treatment Decisions Regarding Chemotherapy

Por Nakamura, Sho, Fukui, Tadahisa, (Ito) Sasahara, Yuriko, Suzuki, Shuhei, Takeda, Hiroyuki, Miwa, Misako, Ichikawa, Mayumi, Nemoto, Kenji, Yamakawa, Mayumi, Yoshioka, Takashi
Publicado no Intern Med (2016)

Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo

Por Takeda, Hiroyuki, Okada, Masashi, Kuramoto, Kenta, Suzuki, Shuhei, Sakaki, Hirotsugu, Sanomachi, Tomomi, Seino, Shizuka, Yoshioka, Takashi, Hirano, Hirofumi, Arita, Kazunori, Kitanaka, Chifumi
Publicado no Oncotarget (2017)